The revolutionary strides in medicine and medical research combine the gift of healing and the ambition of science to create advancements previously only dreamed of in history. Now they are achievable in our lifetime. We believe “Bringing Better Health to the World” is the key to our future.

Warburg Capital Partners provides financial investments in pharmaceutical development and healthcare. Our firm conceives, nurtures, and supports new biotechnology and life sciences including drug development, discovery, and delivery. We also have a core focus in telemedicine and diagnostics.

Warburg Capital Partners seeks to take advantage of this large market opportunity by identifying and investing in and partnering with the best of the new breed of alternative and traditional life science companies.

Warburg Capital Partners sees opportunities across diverse segments of alternative and traditional biotechnology, the fund has a preference for targeting the following areas:

• Drug Discovery
• Drug Development
• Diagnostics
• Medical Devices & Telemedicine